• In 2024, The Centre for Immunization Surveillance (CIS) and the Centre for Emerging Respiratory Infections and Pandemic Preparedness (CERIPP) at PHAC are launching the renewal process for the Canada’s NVCGs and VPD- RTs for 2025-2030 The current slide is repurposed from 4 VCES’s NVCG Renewal Presentation. [...] 8 Part 1.3: Rubella Current: Maintain the elimination status of endemic rubella in Canada Rationale: Endemic rubella has been eliminated Status: Met from Canada since 2005 as a PAHO requirement Considerations for the renewal: • PAHO priority to maintain rubella elimination in the Americas, and WHO priority to eradicate rubella globally. [...] • Should respiratory and cutaneous diphtheria be grouped together in the newly worded target? • If focused on respiratory diphtheria, what would be an appropriate case threshold? Should we maintain cases or frame as hospitalizations? • Is it worth the enhanced investigation to maintain the "exposed in Canada" piece? • Project high resources required to update this target . [...] • Given the disease is not communicable and case counts only reflect vaccination program, should we consider only having a vaccination coverage goal and not a reduction target for tetanus? 12 Part 2.3: Maternal/Neonatal Tetanus (MNT) Current: Maintain zero cases of MNT in Canada Rationale: Eliminated in the Regions of the Status: N/A Americas in 2017 Considerations for the renewal: • Remains a glo. [...] 15 Part 2.6: Invasive Meningococcal Disease (IMD) Current: Maintain less than five cases of IMD serogroup C in children less than 18 years of age Rationale: Target is sufficient to show success of Status: Met vaccination program Considerations for the renewal: • The low incidences in baseline years (2011-2015) are indicative of an effective vaccine and adequate vaccination programs.
Authors
- Pages
- 24
- Published in
- Canada
Table of Contents
- Purpose 2
- Recap - Background 2
- Review of Current Vaccine Preventable Disease Reduction Targets 2
- Disease-specific Considerations 2
- Next Steps 2
- Discussion 2
- Overview 2
- Purpose 3
- Preventable Disease Reduction Targets VPD-RTs is one of five key objectives 4
- 2005 and then renewed in 2016 based on international standards and best 4
- RTs. 4
- PHAC are launching the renewal process for the Canadas NVCGs and VPD- 4
- Recap Background - NVCGs and VPD-RTs 4
- Recap Critical Path Renewal of NVCGs and VPD-RTs 5
- VPD-RTs by 2025 6
- Part 1.1 Polio 7
- Part 1.2 Measles 8
- Current Maintain the elimination status of endemic measles in Canada 8
- Part 1.3 Rubella 9
- Part 2.1 Diphtheria 11
- Part 2.2 Tetanus All 12
- Part 2.3 MaternalNeonatal Tetanus MNT 13
- Current Maintain zero cases of MNT in Canada 13
- Part 2.4 Haemophilus Influenzae Type B Hib 14
- Part 2.5 Mumps 15
- Canada based on 5-year rolling average 15
- Considerations for the renewal 15
- Part 2.6 Invasive Meningococcal Disease IMD 16
- Part 3.1 Invasive Pneumococcal Disease IPD 17
- Part 3.2 Varicella 18
- Part 3.3 Pertussis 19
- Current Maintain an average of less than three deaths annually that are due 19
- Out of 13 DRTs 20
- What is your Score 20
- How many did you get correctly 13 20
- VPD Reduction Targets Overarching Considerations 21
- Next Steps 22
- Are there missing key elements from the planned approach Is the planned approach for PT engagement and approval 24
- Is the list of stakeholders comprehensive enough 24
- Discussion 24
